FENNEC PHARMACEUTICALS INC (FENC)

CA31447P1009 - Common Stock

9.34  -0.23 (-2.4%)

After market: 9.34 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
21.25M1.54M0.00170.00K0.00
Cost Of Goods
1.26M90.00KN/AN/AN/A
Gross Profit
19.99M1.45MN/AN/AN/A
Operating Expenses
32.76M24.03M17.22M18.06M13.01M
Research and Development
56.00K3.53M4.98M5.11M5.61M
Selling, General, and Administrative Expenses
32.71M20.51M12.24M12.95M7.40M
Operating Income
-12.77M-22.59M-17.22M-17.89M-13.01M
Interest Income/Expense
-3.27M-1.13M-120.00K-220.00K250.00K
Other Income/Expense
N/AN/AN/A-10.00K-20.00K
Income Before Taxes
-16.05M-23.71M-17.35M-18.11M-12.78M
Net Income
-16.05M-23.71M-17.35M-18.11M-12.78M
 
Per Share Data
EPS Diluted Total Ops
-0.60-0.90-0.67-0.76-0.64
Non GAAP EPS
-0.61-0.90-0.67-0.77-0.64
 
Statistics
Gross Profit Margin
94.08%94.16%N/AN/AN/A
Profit Margin
-75.50%-1539.61%N/A-10652.94%N/A
Operating Profit Margin
-60.09%-1466.88%N/A-10523.53%N/A

All data in USD

Charts